The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The FTC’s complaint, filed in its administrative court, accuses Express Scripts, Caremark Rx and Optum Rx of “abusing their ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The PBMs say out-of-pocket insulin costs have fallen sharply since 2019. The Pharmaceutical Care Management Association, ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients ...
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big Three" pharmacy benefit managers (PBMs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback